The global business software market will grow 8.2 percent this year and hit $267 billion in revenues as recovery from the global economic downturn starts, according to Ovum.
Chief Information Officers (CIOs) of hospitals plan to significantly increase spending on IT in 2011, results of a survey done by analyst firm Ovum said.
Despite the serious threat posed to enterprises from accidental and malicious misuse of data, uptake of data loss prevention technology will remain low for the next four years, according to Ovum.
The Chinese outsourcing market may soon be at par with India, the current leader, and may eventually overtake it, according to Ovum.
Ovum finds that the risk of sensitive information being divulged on the Web by organizations makes regulation a necessary evil.
While the future shape of Government is Australia will be unclear for some time, sufficient trends are emerging to enable IT managers to undertake some reasonable scenario planning. This is certainly not a time to sit around waiting for an answer, as the news is not all bad for government IT.
Telstra is positioning itself as an e-Health cloud provider, after signing a partnership with the Royal Australian College of General Practitioners (RACGP).
Recent advances in computing, communication, mobility, globalization, rising customer expectation, as well as medical advances resulting in longer lifespan are forcing the various players in the healthcare industry to re-evaluate the role of information and communication technology (ICT).
IT vendors fall into three categories: (1) strategic partners; (2) commodity players; or (3) nitch players. Kevin Noonan, research director, public sector OVUM, looks at each of these categories and how vendors can make money in each category. He also explores the challenges that vendors who want to be in a strategic partner position to achieve higher margins over longer periods.
In April 2010, Oracle signed an agreement to acquire Phase Forward, a provider of e-clinical and drug safety solutions. Almost a year earlier, Oracle purchased Relsys, a provider of drug safety, risk management and analytics. Prior to these acquisitions, Oracle’s life sciences business was mostly around project management, validation and compliance.
